These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8204504)

  • 41. Antisense and siRNA technologies--SMi Conference 12-13 February 2003, London, UK.
    Gotham S
    IDrugs; 2003 Mar; 6(3):211-4. PubMed ID: 12838994
    [No Abstract]   [Full Text] [Related]  

  • 42. The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes.
    Zoumadakis M; Neubert WJ; Tabler M
    Nucleic Acids Res; 1994 Dec; 22(24):5271-8. PubMed ID: 7816616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies to express structural and catalytic RNAs in mammalian cells.
    Thompson JD
    Methods Enzymol; 1999; 306():241-60. PubMed ID: 10432458
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition of mouse hepatitis virus multiplication by antisense oligonucleotide, antisense RNA, sense RNA and ribozyme.
    Mizutani T; Hayashi M; Maeda A; Sasaki N; Yamashita T; Kasai N; Namioka S
    Adv Exp Med Biol; 1993; 342():129-35. PubMed ID: 8209719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drugs made of RNA: development and application of engineered RNAs for gene therapy.
    Drude I; Dombos V; Vauléon S; Müller S
    Mini Rev Med Chem; 2007 Sep; 7(9):912-31. PubMed ID: 17897081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense principle or ribozyme action?
    Sczakiel G; Goody RS
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):745-6. PubMed ID: 7535059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA.
    Liu Z; Batt DB; Carmichael GG
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4258-62. PubMed ID: 8183899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene regulation by antisense RNA and DNA.
    Case CC; Dhundale AR
    Antisense Res Dev; 1991; 1(2):207-17. PubMed ID: 1841663
    [No Abstract]   [Full Text] [Related]  

  • 49. Identifying accessible sites in RNA: the first step in designing antisense reagents.
    Pan WH; Clawson GA
    Curr Med Chem; 2006; 13(25):3083-103. PubMed ID: 17073649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and production of asymmetric hammerhead ribozymes.
    Tabler M; Sczakiel G
    Methods Mol Biol; 1997; 74():141-9. PubMed ID: 9204429
    [No Abstract]   [Full Text] [Related]  

  • 52. An indexed bibliography of antisense literature, 1991.
    Antisense Res Dev; 1992; 2(1):63-107. PubMed ID: 1422087
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of preS2 antisense RNA on hepatocellular carcinoma with a novel delivery system.
    Ma C; Sun W; Tian P; Wang X; Liu S; Zhang L; Cao Y; Zhu F; Zhang Q
    Chin Med J (Engl); 2003 May; 116(5):717-20. PubMed ID: 12875688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The long march of antisense.
    Jones D
    Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
    [No Abstract]   [Full Text] [Related]  

  • 55. The ade6 gene of the fission yeast as a target for antisense and ribozyme RNA-mediated suppression.
    Atkins D; Patrikakis M; Izant JG
    Antisense Res Dev; 1995; 5(4):295-305. PubMed ID: 8746779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
    Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
    Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and function of the hairpin ribozyme.
    Fedor MJ
    J Mol Biol; 2000 Mar; 297(2):269-91. PubMed ID: 10715200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current therapies for glioblastoma.
    Yung WK
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):572-3. PubMed ID: 16163238
    [No Abstract]   [Full Text] [Related]  

  • 59. Making sense of antisense therapy for hypertension.
    Ali ZA
    Hellenic J Cardiol; 2006; 47(3):150-1. PubMed ID: 16862821
    [No Abstract]   [Full Text] [Related]  

  • 60. Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancer in humans.
    Anthony DD; Pan YX; Wu SG; Shen F; Guo YJ
    Adv Exp Med Biol; 1998; 451():27-34. PubMed ID: 10026846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.